Neuren Pharmaceuticals | NEU - Ebit

Stock Price
12.79
Daily Change
-0.06 -0.47%
Monthly
2.48%
Yearly
-3.03%
Q2 Forecast
12.55

Neuren Pharmaceuticals reported AUD17.01M in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Clinuvel Pharmaceuticals AUD 13.51M 15.95M Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Genetic Signatures AUD -6.34M 1.67M Dec/2025
Ionis Pharmaceuticals USD -118M 97M Mar/2026
Medical Developments International AUD -36K 12.96M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 154.09M Dec/2025
Organon & Co USD -27M 415M Dec/2025
Paradigm Biopharmaceuticals AUD -21.57M 11.26M Dec/2025
PYC Therapeutics AUD -22.59M 3.25M Dec/2025
Starpharma Holdings AUD -873K 161K Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 16.77M 8.88M Dec/2025